Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Platform source : Www.biospace.com save search
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Published: 2024-04-19 (Crawled : 12:00) - biospace.com/
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: 0.83%
H: 1.35%
C: 1.2%
XOMA | $25.64 -1.73% -3.9% 8.2K
|
Health Technology
|
| O: 0.87%
H: 7.97%
C: 4.17%
companies biopharma platform
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Co...
Published: 2024-04-18 (Crawled : 18:00) - biospace.com/
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
XOMA | $25.64 -1.73% -3.9% 8.2K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
biopharma platform
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Published: 2024-04-18 (Crawled : 13:00) - biospace.com/
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
XOMA | $25.64 -1.73% -3.9% 8.2K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
companies biopharma platform
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Co...
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
XOMA | $25.64 -1.73% -3.9% 8.2K
|
Health Technology
|
| O: -1.48%
H: 1.08%
C: 0.96%
biopharma platform
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Published: 2024-04-17 (Crawled : 13:00) - biospace.com/
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
XOMA | $25.64 -1.73% -3.9% 8.2K
|
Health Technology
|
| O: -1.48%
H: 1.08%
C: 0.96%
companies biopharma platform
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Co...
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
XOMA | $25.64 -1.73% -3.9% 8.2K
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: -0.97%
biopharma platform
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
XOMA | $25.64 -1.73% -3.9% 8.2K
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: -0.97%
companies biopharma platform
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Co...
Published: 2024-04-15 (Crawled : 06:00) - biospace.com/
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
XOMA | $25.64 -1.73% -3.9% 8.2K
|
Health Technology
|
| O: -2.63%
H: 1.39%
C: -3.3%
biopharma platform
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Published: 2024-04-15 (Crawled : 06:00) - biospace.com/
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
XOMA | $25.64 -1.73% -3.9% 8.2K
|
Health Technology
|
| O: -2.63%
H: 1.39%
C: -3.3%
companies biopharma platform
BPGbio Presents Key Advances in its Oncology Pipeline related to the NAi Interrogative Biology Platform
Published: 2024-04-05 (Crawled : 13:30) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: -1.81%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -3.44%
H: 0.0%
C: 0.0%
pipeline key platform
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform
Published: 2024-04-02 (Crawled : 14:30) - biospace.com/
VBIV | $0.59 -3.04% -3.26% 130K
|
Health Technology
| Email alert
Add to watchlist
partnership vaccine platform
GRAIL Presents New Data on Galleri® and Its Methylation Platform at the Annual American Association for Cancer Research (AACR) Meeting
Published: 2024-03-27 (Crawled : 23:00) - biospace.com/
ILMN | $122.87 -1.28% -1.4% 720K
|
Health Technology
|
| O: 1.28%
H: 2.34%
C: 2.34%
galleri association cancer research meeting platform
NIMML Institute’s TITAN-X A.I.-Powered Precision Medicine Platform Validated through AbbVie’s Acquisition of Landos Biopharma and Lead Clinical Candidate NX-13
Published: 2024-03-25 (Crawled : 00:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
|
| O: 1.19%
H: 0.11%
C: -0.26%
nx-13 candidate precision biopharma acquisition platform
NLS Pharmaceutics Secures Exclusive Global License for Next-Generation Non-Sulfonamide Dual Orexin Agonist Platform
Published: 2024-03-20 (Crawled : 13:00) - biospace.com/
NLSP | $0.125 -3.99% 3.64% 36K
|
|
| O: 7.65%
H: 31.03%
C: -45.86%
agonist license global platform
Arrayjet’s ArrayPlex Platform Selected by Immunome for Use in Its Discovery of Targeted Cancer Therapies
Published: 2024-03-18 (Crawled : 11:00) - biospace.com/
IMNM | $14.27 -2.66% -2.66% 560K
|
Health Technology
|
| O: -1.02%
H: 3.1%
C: -0.67%
cancer platform
Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform
Published: 2024-03-14 (Crawled : 12:00) - biospace.com/
ZOM | $0.1302 -0.84% 0.92% 2.5M
|
Miscellaneous
|
| O: -4.89%
H: 2.87%
C: 1.66%
test diagnostic publication research platform
908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares’ Fully Integrated Cell Therapy Manufacturing Platform
Published: 2024-02-29 (Crawled : 16:00) - biospace.com/
MASS | $5.62 1.08% 0.71% 160K
|
|
| O: 4.01%
H: 1.67%
C: -5.53%
cell therapy platform
Bristol Myers Squibb Completes Acquisition of RayzeBio, Adding Differentiated Actinium-Based Radiopharmaceutical Platform
Published: 2024-02-26 (Crawled : 14:00) - biospace.com/
BMY | $48.86 -0.27% 0.98% 14M
|
Health Technology
|
| O: -0.19%
H: 0.23%
C: -2.02%
acquisition platform
Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease
Published: 2024-02-20 (Crawled : 15:30) - biospace.com/
BTTX | $0.0078 30.0% -65.02% 0
|
|
| O: 7.55%
H: 2.13%
C: -27.83%
fda device liver disease designation therapeutics advanced platform
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
Published: 2024-02-15 (Crawled : 12:00) - biospace.com/
DGX | News | $137.55 0.62% 0.0% 6
|
Health Services
|
| O: 0.22%
H: 0.7%
C: -1.77%
million cancer funding platform
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
MTH | $154.69 -2.21% 12.68% 450K
|
Consumer Durables
HCP | News | $31.41 7.75% 11.26% 17M
|
TSLA | News | $162.13 12.06% 10.13% 170M
|
Consumer Durables
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.